Keywords: CIS، کارسینوم در محل; ureter; urinary bladder neoplasms; carcinoma; constriction, pathologic; recurrenceBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CTU, computerized tomography urography; IMPDU, intramural portion of distal ureter; MMC, mitomycin C; NMIBC, nonmuscle
مقالات ISI CIS، کارسینوم در محل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; recurrence; disease progression; Mycobacterium bovis; mitomycinBC, bladder cancer; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CS, conditional survival; NMIBC, nonmuscle invasive BC; TURB, transurethral resection of b
Keywords: CIS، کارسینوم در محل; CIS, carcinoma in situ; NBI, Narrow Band Imaging Bronchoscopy; NPV, negative predictive value; PPV, positive predictive value; WLB, white light bronchoscopyNarrow band imaging (NBI); White light bronchoscopy (WLB); Premalignant lesions; Carcinoma in situ
Keywords: CIS، کارسینوم در محل; CIS, carcinoma in situ; ESD, endoscopic submucosal dissection; HGIN, high-grade intraepithelial neoplasia; LST, laterally spreading tumor; LST-G-H, laterally spreading tumor homogeneous; LST-G-M, laterally spreading tumor nodular mixed; LST-NG-F, laterall
Keywords: CIS، کارسینوم در محل; drug therapy; neoadjuvant therapy; eligibility determination; urinary bladder neoplasms; quality indicators; health careASA®, American Society of Anesthesiologists®; CIS, carcinoma in situ; CrCl, creatinine clearance; NAC, neoadjuvant chemotherapy
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; disease progression; BCG vaccine; drug therapy; administration; intravesicalBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; MMC, mitomycin C; NMIBC, nonmuscle invasive bladder cancer; TURBT, transurethral resection of the
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; surgical procedures; operativeAUA, American Urological Association; BCa, bladder cancer; BCG, bacillus Calmette-Guérin; BL, blue light; CIS, carcinoma in situ; EAU, European Association of Urology; FDA, Food and Drug Administrat
Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer
Keywords: CIS، کارسینوم در محل; mycobacterium bovis; administration and dosage; urinary bladder neoplasms; quality of life1/2D, half dose; 1/3D, one-third dose; 1/6D, one-sixth dose; AE, adverse event; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; CUETO,
A comparative study between full-dose and half-dose intravesical immune bacille Calmette–Guérin injection in the management of superficial bladder cancer
Keywords: CIS، کارسینوم در محل; NMIBC, non-muscle-invasive bladder cancer; CIS, carcinoma in situ; TURBT, transurethral resection of the bladder tumourBCG; TCC; Non-muscle-invasive; Bladder cancer
The Effect of Concomitant Carcinoma In Situ on Neoadjuvant Chemotherapy for Urothelial Cell Carcinoma of the Bladder: Inferior Pathological Outcomes but No Effect on Survival
Keywords: CIS، کارسینوم در محل; urinary bladder; carcinoma in situ; urothelium; neoadjuvant therapy; drug therapycCIS, concomitant CIS; CIS, carcinoma in situ; CSS, cancer specific survival; MIBC, muscle invasive bladder cancer; MVAC, methotrexate, vincristine, doxorubicin and cisplatin
Low-dose bacille Calmette–Guérin for non-muscle-invasive bladder cancer: Results of a prospective study
Keywords: CIS، کارسینوم در محل; BC, bladder cancer; CIS, carcinoma in situ; NMI, non-muscle-invasive; SWOG, Southwest Oncology Group; TURB, transurethral resection of the bladderBCG; Bladder cancer; Low-dose regimen; NMIBC; TURB
ΔNp63 Expression is a Protective Factor of Progression in Clinical High Grade T1 Bladder Cancer
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; TP63 protein; human; biological markers; disease progression; prognosisBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; DSS, disease specific survival; HGT1, high grade T1; MID, muscle invasive disease; NMIBC, nonmuscle in
Combining Mitomycin C and Regional 70 MHz Hyperthermia in Patients with Nonmuscle Invasive Bladder Cancer: A Pilot Study
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; neoplasm recurrence; local; hyperthermia; induced; mitomycin; adverse effectsBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; EAU, European Association of Urology; MMC, mitomycin C; NMIBC, nonmuscle invasive bladder cancer
Efficacy and Safety of MCNA in Patients with Nonmuscle Invasive Bladder Cancer at High Risk for Recurrence and Progression after Failed Treatment with bacillus Calmette-Guérin
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; BCG vaccine; treatment failure; Mycobacterium phlei; nucleic acidsAE, adverse event; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; DFS, disease-free survival; ITT, intent to treat; MCNA, Mycobacte
The Effect of Restaging Transurethral Resection on Recurrence and Progression Rates in Patients with Nonmuscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guérin
Keywords: CIS، کارسینوم در محل; urinary bladder; carcinoma; BCG vaccine; neoplasm recurrence; local; reoperationBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; NMIBC, nonmuscle invasive bladder carcinoma; TUR, transurethral resection
Prostate Sparing Cystectomy for Bladder Cancer: 20-Year Single Center Experience
Keywords: CIS، کارسینوم در محل; prostate; urinary bladder neoplasms; carcinoma; transitional cell; cystectomy; disease-free survivalBC, bladder cancer; CIC, clean intermittent catheterization; CIS, carcinoma in situ; CT, computerized tomography; DSS, disease specific survival; HR-QL, he
Phase II Trial of Intravesical Nanoparticle Albumin Bound Paclitaxel for the Treatment of Nonmuscle Invasive Urothelial Carcinoma of the Bladder after bacillus Calmette-Guérin Treatment Failure
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; intravesical administration; therapies; investigational; paclitaxel; nanotechnologyBCG, bacillus Calmette-Guérin; CFS, cystectomy-free survival; CIS, carcinoma in situ; CR, complete response; MDD, maximal deliverable dose; nab,
Impact of ABO Blood Type on Outcomes in Patients with Primary Nonmuscle Invasive Bladder Cancer
Keywords: CIS، کارسینوم در محل; urinary bladder; carcinoma; ABO blood-group system; neoplasm recurrence; local; disease progressionc index, concordance index; CIS, carcinoma in situ; CUETO, Spanish Urological Club for Oncological Treatment; MMC, mitomycin C; NMIBC, nonmuscle invasive UC
Combined Chemohyperthermia: 10-Year Single Center Experience in 160 Patients with Nonmuscle Invasive Bladder Cancer
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; drug therapy; body temperature changes; BCG vaccine; neoplasm recurrence; localAE, adverse event; BCG, bacillus Calmette-Guérin; CHT, chemohyperthermia; CIS, carcinoma in situ; CR, complete response; EPI, epirubicin; MMC, mitomy
Clinical Outcome of Patients with T1 Micropapillary Urothelial Carcinoma of the Bladder
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; BCG vaccine; cystectomy; treatment outcomeBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CSM, cancer specific mortality; CSS, cancer specific survival; LVI, lymphovascular invasion; MPC, micropapillary component; NED, no
Reassessment of Prognostic Heterogeneity of pT3 Renal Pelvic Urothelial Carcinoma: Analysis in Terms of Proposed pT3 Subclassification Systems
Keywords: CIS، کارسینوم در محل; kidney; carcinoma; neoplasm invasiveness; neoplasm staging; prognosisAJCC, American Joint Committee on Cancer; CIS, carcinoma in situ; CSS, cancer specific survival; EAU, European Association of Urology; LN, lymph node; PA, predictive accuracy; RFS, recur
Genomic DNA copy number alterations from precursor oral lesions to oral squamous cell carcinoma
Keywords: CIS، کارسینوم در محل; LGD, low grade dysplasia; HGD, high grade dysplasia; CIS, carcinoma in situ; OSCC, oral squamous cell carcinomaCopy number alterations; Oral lesions; Oral cancer; Oral squamous cell carcinoma; Array comparative genomic hybridization
A Prospective Comparative Study of Intravesical Bacillus Calmette-Guérin Therapy with the Tokyo or Connaught Strain for Nonmuscle Invasive Bladder Cancer
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; BCG vaccine; BCG Connaught; treatment outcome; JapanBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; NMIBC, nonmuscle invasive bladder cancer; RFS, recurrence-free survival; TURBT, transurethral rese
Intravesical Gemcitabine for High Risk, Nonmuscle Invasive Bladder Cancer after Bacillus Calmette-Guérin Treatment Failure
Keywords: CIS، کارسینوم در محل; urinary bladder; urinary bladder neoplasms; BCG vaccine; treatment failure; gemcitabineBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; CSS, cancer specific survival; MIBC, muscle invasive bladder cancer; NMIBC, nonMIBC; NR, n
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial
Keywords: CIS، کارسینوم در محل; gemcitabine; BCG Connaught; urinary bladder neoplasms; quality of life; risk assessmentBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CTCAE, Common Terminology Criteria for Adverse Events; GEM, gemcitabine; NMIBC, nonmuscle invasive bladder cancer
Impact of Statin Use on Oncologic Outcomes in Patients with Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy
Keywords: CIS، کارسینوم در محل; urinary bladder; urinary bladder neoplasms; neoplasm recurrence; mortality; hydroxymethylglutaryl-CoA reductase inhibitorsBMI, body mass index; CIS, carcinoma in situ; LVI, lymphovascular invasion; RC, radical cystectomy; STSM, positive soft tissue surgic
Disorders of sexual differentiation: I. Genetics and pathology
Keywords: CIS، کارسینوم در محل; CIS, carcinoma in situ; DSD, disorder(s) of sexual differentiation; SRY, sex-determining region on the Y chromosome; SF-1, steroidogenic factor 1; WT-1, Wilms’ tumour-1 gene; MIS, Müllerian-inhibiting substance; MGD, mixed gonadal dysgenesis; CAH, congeni
High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer
Keywords: CIS، کارسینوم در محل; BCG, Bacillus Calmette-Guérin; CI, confidence interval; CIS, carcinoma in situ; DC, dendritic cells; EORTC, European Organization for Research and Treatment of Cancer; HR, hazard ratio; TAM, tumor-associated macrophage; TIDC, tumor-infiltrating dendritic
Efficacy and Safety of Photodynamic Therapy for Recurrent, High Grade Nonmuscle Invasive Bladder Cancer Refractory or Intolerant to Bacille Calmette-Guérin Immunotherapy
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; photochemotherapy; chlorin e6; BCG vaccine; treatment failure5-ALA, 5-aminolevulinic acid; AE, adverse effect; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; HAL, hexaminolevulinic acid; LUTS, lower urinary tract symptom
Prognostic Interest in Discriminating Muscularis Mucosa Invasion (T1a vs T1b) in Nonmuscle Invasive Bladder Carcinoma: French National Multicenter Study with Central Pathology Review
Keywords: CIS، کارسینوم در محل; urinary bladder; neoplasm invasiveness; mucous membrane; prognosis; FranceBC, bladder cancer; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CSS, cancer specific survival; LP, lamina propria; MM, muscularis mucosa; MP, muscularis propria; NMIBC, n
Global analysis of DNA methylation changes during progression of oral cancer
Keywords: CIS، کارسینوم در محل; OSCC, oral squamous cell carcinoma; CIS, carcinoma in situ; OPL, oral premalignant lesion; FV, fluorescence visualizationOral cancer; Dysplasia; Methylation; Progression; Field effect; Epigenetics
External Validation of a Biomarker Based Pre-Cystectomy Algorithm to Predict Nonorgan Confined Urothelial Cancers
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; neoplasm staging; nomogramsCA 19–9, carbohydrate antigen 19–9; CA 125, carbohydrate antigen 125; CEA, carcinoembryonic antigen; CIS, carcinoma in situ; PCA, principal component analysis; TUR, transurethral resection
Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; mycobacterium bovis; in situ hybridization; fluorescence; treatment outcome; prognosisBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; FISH, fluorescence in situ hybridization; NMIBC, nonmuscle invasive bladder cancer; TUR
A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin
Keywords: CIS، کارسینوم در محل; immunotoxins; carcinoma in situ; urinary bladder; administration; intravesical; clinical trials; phase IIAE, adverse event; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; EOS, end of study; EpCAM, epithelial cell adhesion mo
Prognostic Value of Extranodal Extension and Other Lymph Node Parameters in Patients With Upper Tract Urothelial Carcinoma
Keywords: CIS، کارسینوم در محل; urinary tract; urothelium; carcinoma; neoplasm metastasis; lymph node excisionAJCC, American Joint Committee on Cancer; CIS, carcinoma in situ; ENE, extranodal extension; LN, lymph node; LNM, LN metastasis; RNU, radical nephroureterectomy; UTUC, upper tra
New Optical Imaging Technologies for Bladder Cancer: Considerations and Perspectives
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; fluorescence; cystoscopy; lasers; tomography; optical coherence5-ALA, 5-aminolevulinic acid; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CLE, confocal laser endomicroscopy; HAL, hexaminolevulinate; NBI, narrow band im
Urinary pH Is Highly Associated With Tumor Recurrence During Intravesical Mitomycin C Therapy for Nonmuscle Invasive Bladder Tumor
Keywords: CIS، کارسینوم در محل; urinary bladder; urothelium; carcinoma; neoplasm recurrence; local; mitomycinBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; MMC, mitomycin C; NMIBC, nonmuscle invasive bladder cancer; TUR-BT, bladder cancer transurethral resection
Paclitaxel-Hyaluronic Acid for Intravesical Therapy of Bacillus Calmette-Guérin Refractory Carcinoma In Situ of the Bladder: Results of a Phase I Study
Keywords: CIS، کارسینوم در محل; paclitaxel; hyaluronic acid; administration; intravesical; carcinoma in situ; urinary bladderAEs, adverse events; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; DLT, dose limiting toxicity; HA, hyaluronic acid; NMIBC, nonmus
Factors Affecting Response to Bacillus Calmette-Guérin Plus Interferon for Urothelial Carcinoma in Situ
Keywords: CIS، کارسینوم در محل; urinary bladder; urothelium; carcinoma in situ; BCG vaccine; interferonsBCG, bacillus Calmette-Guérin; BCG-N, BCG naïve; BCG-F, BCG failure; CIS, carcinoma in situ; IFN, interferon; NMIBC, nonmuscle invasive bladder cancer
The role of early re-resection in pTaG3 transitional cell carcinoma of the urinary bladder
Keywords: CIS، کارسینوم در محل; ASA, American Society of Anesthethiology; BCG, Bacillus Calmette-Guérin; CIS, carcinoma in situ; EAU, European Association of Urology; IVU, intravenous urogram; MDT, Multi Disciplinary Team; NICE, National Institute of Health and Clinical Excellence; TCC,
Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a
Keywords: CIS، کارسینوم در محل; 5-aza-dC, 5-aza-2′-deoxycytidine; CIS, carcinoma in situ; DEN, diethylnitrosamine; DNMTs, DNA methyltransferases; MCA, 3-methylcholanthrene; MSP, methylation-specific polymerase chain reaction; NSCLC, non-small cell lung cancer; RT-PCR, reverse transcript
A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; clinical protocols; administration; intravesical; drug therapy; mycobacterium bovisAUA, American Urological Association; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; EAU, European Association of Urology; EORTC, Europea
Pro-inflammatory type-1 and anti-inflammatory type-2 macrophages differentially modulate cell survival and invasion of human bladder carcinoma T24 cells
Keywords: CIS، کارسینوم در محل; BCG, Bacillus Calmette-Guerin; CIS, carcinoma in situ; CM, conditioned media; GM-CSF, granulocyte/macrophage-colony stimulating factor; IFN, interferon; IL, interleukin; LPS, lipopolysaccharide; Mϕs, macrophages; MTT, methylthiazolyldiphenyl-tetrazolium b
pT3 Substaging is a Prognostic Indicator for Lymph Node Negative Urothelial Carcinoma of the Bladder
Keywords: CIS، کارسینوم در محل; urinary bladder; urothelium; carcinoma; mortality; neoplasm stagingAJCC, American Joint Committee on Cancer; CIS, carcinoma in situ; LN, lymph node; LVI, lymphovascular invasion; STSM, soft tissue surgical margin; UCB, urothelial carcinoma of the bladder
Bacillus Calmette-Guérin With or Without Interferon α-2b and Megadose Versus Recommended Daily Allowance Vitamins During Induction and Maintenance Intravesical Treatment of Nonmuscle Invasive Bladder Cancer
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; mycobacterium bovis; interferons; vitaminsBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; IFN-α2b, interferon α-2b; NMIBC, nonmuscle invasive bladder cancer; RDA, recommended daily allowance; Th1, T helper cell type 1; TU
Safety and Efficacy of Intravesical Bacillus Calmette-Guérin Plus Interferon α-2b Therapy for Nonmuscle Invasive Bladder Cancer in Patients With Prosthetic Devices
Keywords: CIS، کارسینوم در محل; bladder; bladder neoplasms; BCG vaccine; interferons; prostheses and implantsAHV, artificial heart valve; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; NMIBC, nonmuscle invasive bladder cancer
Survival after cystectomy for invasive bladder cancer
Keywords: CIS، کارسینوم در محل; Bladder neoplasms; Cystectomy; Transitional cell carcinoma; Survival; High-risk non-muscle-invasive bladder cancerNMIBC, non-muscle-invasive bladder cancer; HR, hazard ratio; CIS, carcinoma in situ; TUR, transurethral resection; BCG, Bacillus Calmette Gué
Clinical Outcome of Primary Versus Secondary Bladder Carcinoma In Situ
Keywords: CIS، کارسینوم در محل; urinary bladder; carcinoma; Mycobacterium bovis; carcinoma in situ; urinary bladder neoplasmsBCG, bacillus Calmette-Guerin; CIS, carcinoma in situ; RC, radical cystectomy; TUR, transurethral resection; UBC, urothelial bladder carcinoma
Absent CD44v6 Expression is an Independent Predictor of Poor Urothelial Bladder Cancer Outcome
Keywords: CIS، کارسینوم در محل; urinary bladder neoplasms; urothelium; risk; mortality; antigens, CD44BC, urothelial bladder cancer; CD44v, CD44 variant; CIS, carcinoma in situ; TUR, transurethral resection
Characteristics and Outcomes of Patients With Clinical Carcinoma In Situ Only Treated With Radical Cystectomy: An International Study of 243 Patients
Keywords: CIS، کارسینوم در محل; carcinoma in situ; prognosis; urinary bladder neoplasms; carcinoma; transitional cell; survivalBCG, bacillus Calmette-Guerin; CIS, carcinoma in situ; LVI, lymphovascular invasion; RC, radical cystectomy; SEER, Surveillance, Epidemiology and End Results; T